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Abstract 
High rates of comorbidity are found among eating disorder (ED) patients, which may 
negatively affect treatment outcome and prognosis. However, there is a shortage of studies in 
Spain using clinician administered interviews to assess rates of comorbidity among these 
patients, particularly in adolescents. This study aimed to evaluate Axis I psychiatric 
diagnoses in adolescent patients with an ED and to compare them with patients with a distinct 
disorder with adolescent onset, substance use disorder (SUD) patients. Considering that 
maternal psychological distress is another factor involved in ED prognosis, a secondary aim 
was to examine the relationship between patient´s psychological variables and maternal 
distress (depression and anxiety). The cross-sectional study included 50 ED patients, 48 SUD 
patients, and their mothers. More than half of the patients received a diagnosis for a comorbid 
disorder. Internalizing problems were more common among EDs and externalizing disorders 
were the most common comorbidities among SUDs, similar to findings from other countries. 
Maternal distress was associated with higher levels of depression and symptom severity in 
patients. No differences in distress were found between mothers of patients with a comorbid 
diagnosis and those without. Elevated anxiety or depression in mothers did not increase the 
likelihood of patients having a particular primary diagnosis. In short, while both ED and SUD 
patients presented high rates of comorbidity, the types of comorbid diagnoses were specific 
to each group. Assessing for the presence of comorbid disorders and targeting maternal 
psychological distress may guide treatment interventions and improve patient prognosis.  
 
 
Keywords: eating disorders; substance use disorders; comorbidity; caregivers; diagnostic 
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1. Introduction 
Eating disorders (EDs) are chronic mental illnesses, with a typical onset during 
adolescence or early adulthood (American Psychiatric Association, 2013), and significantly 
elevated mortality rates, particularly in the case of Anorexia Nervosa (AN) (Arcelus, 
Mitchell, Wales, & Nielsen, 2011). Another group of chronic, life threatening mental 
illnesses with a similar age of onset are substance use disorders (SUDs) (Oyefeso, Ghodse, 
Clancy, Corkery, & Goldfinch, 1999; Smink, van Hoeken, & Hoek, 2012). Both present a 
long recovery process (American Academy of Pediatrics, 2011) and high risk of poor 
prognosis (American Academy of Pediatrics, 2011; Steinhausen, 2002). Furthermore, they 
share a multifactorial etiology, involving a combination of genetic, biological and personality 
vulnerabilities that interact with environmental factors (Davis & Claridge, 1998; Emmelkamp 
& Vedel, 2012; Fairburn & Harrison, 2003; Klump, Bulik, Kaye, Treasure, & Tyson, 2009).   
Both EDs and SUDs present high rates of comorbidity, with 40 to 98% of AN patients 
in particular (Blinder, Cumella, & Sanathara, 2006; Bühren et al., 2014; Salbach-Andrae et 
al., 2008), and 40 to 90% of SUD patients (Armstrong & Costello, 2002; Chan, Dennis, & 
Funk, 2008; Langenbach et al., 2010; Shrier, Harris, Kurland, & Knight, 2003) reporting a 
comorbid Axis I diagnosis. The most frequent comorbid diagnoses among ED patients are 
mood disorders, followed by anxiety disorders and obsessive-compulsive disorder (OCD) 
(Blinder et al., 2006; Bühren et al., 2014; Jordan et al., 2008; Salbach-Andrae et al., 2008). In 
SUD patients, conduct disorder (CD) and oppositional defiant disorder (ODD) are the most 
frequent comorbid diagnoses, although a strong association has been found with depression 
(Armstrong & Costello, 2002; Chan et al., 2008; Couwenbergh et al., 2006), a weaker one 
with anxiety (Armstrong & Costello, 2002; Chan et al., 2008), and an ascending trend of 
comorbidity rates have been found with attention-deficit/hyperactivity disorder (ADHD) as 
well (Couwenbergh et al., 2006).  
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A recent study highlighted the need for additional research on comorbidity rates 
among adolescents ED patients, particularly those with AN, as the majority of research to 
date has involved adult samples despite the fact that ED onset typically takes place during 
adolescence (Bühren et al., 2014). Psychiatric comorbidity appears to be associated with 
worse long term prognosis for both SUD (Grella, Hser, Joshi, & Rounds-Bryant, 2001) and 
ED (Herpertz-Dahlmann et al., 2001).  While information regarding rates of comorbidity and 
common comorbid diagnoses may aid mental health professionals working with these 
patients, in Spain in particular, very few studies have assessed rates of psychiatric 
comorbidity in either patient sample (Couwenbergh et al., 2006; Godart, Flament, Perdereau, 
& Jeammet, 2002; Godart et al., 2007). Furthermore, the use of diagnostic interviews to 
assess prevalence rates of EDs is relatively recent in Spain (Peláez Fernández, Raich 
Escursell, & Labrador Encinas, 2010) in spite of the fact that semi-structured diagnostic 
interviews have long been considered the ¨gold-standard¨ for assessing the presence of 
psychiatric disorders as they are more reliable than other forms of assessment (Jewell, 
Handwerk, Almquist, & Lucas, 2004; Peterson, Ranson, & Hodgins, 2014).  
 Research on both EDs and SUDs have seen a shift in recent years, taking into 
consideration not only the patient, but the family as well (Anastasiadou, Medina-Pradas, 
Sepulveda, & Treasure, 2014; Templeton, Velleman, & Russell, 2010), revealing that family 
members report increased levels of stress and strain (Orford, Velleman, Copello, Templeton, 
& Ibanga, 2010; Treasure et al., 2001). Within the field of ED research, this distress is one 
component of the interpersonal maintenance model of AN (Treasure & Schmidt, 2013), 
which provides a theoretical framework for understanding the relationship between patient 
and family variables. This model posits that the high levels of distress reported by family 
members may be risk factors preceding illness onset, as well as maintenance factors which 
influence prognosis (Anastasiadou, Cuellar-Flores, Sepulveda, Parks, & Graell, 2016; 
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Treasure et al., 2008). To date, studies assessing the distress experienced by ED family 
members have not used exclusively adolescent samples and most do not include a 
comparison group, which makes it difficult to know if the relationship between patient and 
family variables are unique to ED or are generalizable to family members of patients with 
other chronic mental illnesses (Anastasiadou et al., 2014). There is reason to believe that the 
latter may be true considering that the broader literature on child and adolescent 
psychopathology suggests that there is an association between mother’s mental health and 
their children’s behavioral problems and emotional functioning (Goodman et al., 2011).   
The primary objective of this study was to use semi-structured diagnostic interviews 
to assess rates of psychiatric Axis I comorbidities in treatment-seeking adolescent ED and 
SUD patients and to compare these two groups on the type and frequency of psychiatric 
diagnoses, and other sociodemographic variables. A secondary objective was to assess the 
relationship between patients´ psychological variables and mothers´ levels of distress.  
In regards to our hypotheses, we predicted that the rates of comorbidity and types of 
comorbidity for both groups would be similar to those found in prior studies carried out in 
other Western countries with treatment seeking adolescents (i.e. more internalizing problems 
in the ED group and more externalizing problems in the SUD group). We also expected to 
find an association between mother and patient variables in both groups, independent of the 
patient´s primary diagnosis.  
2. Method 
2.1 Participants 
Forty-nine females and 1 male (Mean age = 14.8; SD = 1.8, Range: 12-18) diagnosed 
with an ED were compared with 8 females and 40 males (Mean age = 18.2; SD = 2.2, Range: 
13-23) diagnosed with a SUD.  The patients’ mothers were also enrolled in this study.  
2.2 Procedure 
COMORBIDITY IN ADOLESCENT EATING DISORDER PATIENTS 
 5 
A cross-sectional study with a descriptive and comparative design was carried out. The 
inclusion criteria for patients were: 1) 12 to 23 years old; 2a) for the ED group: presence of 
an ED according to DSM-IV-TR diagnostic criteria, 2b) for the SUD group: presence of a 
SUD according to DSM-IV-TR diagnostic criteria, 3) living with at least one parent. Patients 
were excluded if they had a diagnosis of psychosis, a learning disability, a neurologic disease 
or a disease affecting metabolic regulation (i.e. diabetes, hyperthyroidism) or comorbid ED 
and SUD. Data were collected from October 2011 to July 2014. The research was reviewed 
and approved by an institutional review board (R-009/10), all participation was voluntary and 
participants provided informed consent.  
ED patients and their mothers were randomly recruited from consecutive admissions 
to inpatient and outpatient services at the Eating Disorders Unit of the Child and Adolescent 
Psychiatric Department of the Niño Jesus University Hospital, Madrid, Spain.  A total of 53 
patients were approached for the study, one female and one male patient with comorbid SUD 
were not approached. Two of the patients who were approached declined participation due to 
distrust regarding confidentiality of their personal information. Then, three of the authors 
(D.A., M.P. & M.G.) carried out semi-structured clinical interviews and one patient was 
excluded because she presented psychotic symptoms. 
 SUD patients and their mothers were randomly recruited from the adolescent 
outpatient clinic of “Programa Soporte” (Support Program), which is part of Proyecto 
Hombre, an association based in Madrid which provides treatment to adolescents and young 
adults with substance abuse and dependence related problems, as well as their families. 
Forty-eight of the 55 families who were invited to participate provided informed consent and 
underwent the semi-structured clinical interview carried out by D.A. Seven families declined 
participation due to lack of time and/or distrust regarding the confidentiality of their personal 
information. Two adolescents (one female and one male)  had comorbid ED and were not 
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approached. All SUD patients that were interviewed met the selection criteria and were 
included in the study. Following the interview, patients and their mothers completed a set of 
self-report instruments detailed below.  
2.3 Instruments 
2.3.1 Patients and Mothers 
Demographic and clinical characteristics were collected using a clinical interview 
designed for the specific purposes of the study. Mothers provided their age, education level, 
marital status, employment situation and history of psychiatric illness. Age, gender and 
illness duration was collected from all patients. The researcher conducting the interview 
measured the weight and height of the patient in order to calculate BMI.  
The Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-
SADS-PL) (Kaufman et al., 1997) is a semi-structured diagnostic interview capable of 
generating 32 DSM-IV Axis I child psychiatric diagnoses. It consists of an introductory 
interview, diagnostic interview and supplementary diagnostic interview questions, which are 
administered when deemed relevant. The interview was carried out in the presence of the 
patient and responses were confirmed with mothers if the interviewer had doubts. The 
interview has been validated for use in Spain (De la Peña et al., 2002; Ulloa et al., 2006) and 
a pilot study proposed the extension of the K-SADS to young adults aged 18-25 years, 
although results have not yet been published (National Institute of Mental Health, 2016). For 
the current study we only considered current episodes of mental disorders.   
2.3.2 ED patients 
The Eating Attitudes Test (EAT-26) (Garner, Olmsted, Bohr, & Garfinkel, 1982) is a 
26-item questionnaire with a six‐point Likert-type scale (range 0–5) used to assess disordered 
eating behaviors. Scores of 20 or more indicate ED pathology although these scores alone 
cannot yield a specific ED diagnosis. The questionnaire is highly reliable and valid (Garner et 
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al., 1982) and its Spanish version has demonstrated satisfactory psychometric properties 
(Castro, Toro, Salamero, & Guimera, 1991).  
2.3.3 SUD patients 
The Drug Abuse Screening Test (DAST-20) (Skinner & Goldberg, 1986) consists of 
20 items scored on a two-point Likert scale  (1 = yes, 0 = no). It measures problematic drug 
use and associated consequences and a total score of six or above suggests possible drug 
abuse (Skinner & Goldberg, 1986). The questionnaire has shown good internal consistency 
(Saltstone, Halliwell, & Hayslip, 1994; Skinner, 1982) with Cronbach’s alpha of .84 and .78 
for men and women, respectively. The instrument has been validated in Spain in an adult 
population (Pérez Gálvez, García Fernández, de Vicente Manzanaro, Oliveras Valenzuela, & 
Lahoz Lafuente, 2010) and is considered valid and reliable.   
2.3.4. For both patients and their mothers 
The Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983), is 
designed to detect the presence and severity of anxiety and depression in both adults and 
adolescents (White, Leach, Sims, Atkinson, & Cottrell, 1999). It is comprised of 14 items, 
scored on a four-point Likert-type scale. While the factor structure has been debated, several 
studies exploring the psychometric properties of the Spanish version of the instrument have 
confirmed a two-factor structure (Terol-Cantero, Cabrera-Perona, & Martín-Aragón, 2015). 
The items are equally distributed in two subscales: anxiety (7 items) and depression (7 items). 
Scores of 11 or more on each subscale indicate probable anxiety or depression. The original 
version of the instrument obtained satisfactory reliability, with Cronbach’s alpha of .86 for 
each subscale. The Spanish version has shown satisfactory internal consistency of .86 for the 
anxiety subscale and .87 for the depression subscale (Herrero et al., 2003).  
2.4 Statistical analysis 
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Data were analyzed using SPSS 20.0 (SPSS, 2011) for Windows and the criterion for 
significance was set at p value of 0.05. Kolmogorov–Smirnov tests confirmed that the data 
followed a normal distribution and parametric tests were used. The patients’ continuous 
sociodemographic and clinical data were compared using independent samples t-test. 
Patients’ categorical sociodemographic and clinical variables and mothers’ sociodemographic 
variables were described using contingency tables and compared using χ2 test or Fisher exact 
test, as appropriate. When comorbidity with a specific DSM-IV Axis I disorder was absent in 
one of the two groups, no χ2 test or Fisher exact test was performed. The relationship between 
the patients’ scores on psychological measures and mothers’ HADS scores was investigated 
using Pearson’s correlation coefficient, separately for each group of patients. The relationship 
between mother’s HADS scores and having a child with a comorbid disorder was explored 
using independent sample t-tests. 
A series of logistic regression analyses were performed to identify which of the 
psychiatric comorbidities had a significant independent association with the likelihood that 
patients belonged to either the ED or SUD group. Mothers’ anxiety and depression were also 
each entered into a model as possible predictor variables and were categorized using HADS 
suggested cut-off points: absence of or low levels of anxiety/depression (0 = HADS-
Anxiety/HADS-Depression <11) and probable presence of anxiety/depression (1 = HADS-
Anxiety/HADS-Depression ≥11). Axis I disorders were grouped into three main categories 
(unipolar mood disorders, anxiety disorders, ADHD). Disruptive behavior disorders (CD, 
ODD) were not included as a predictor variable due to the complete absence of this type of 
comorbidity in the ED group. All independent variables were categorical (0 = absence of 
psychiatric comorbidity; 1 = presence of psychiatric comorbidity).  
3. Results 
3.1 Demographic and clinical data 
COMORBIDITY IN ADOLESCENT EATING DISORDER PATIENTS 
 9 
Detailed demographic and clinical data for the patients is provided in Table 1. In 
regards to the mother´s sociodemographic data, ED mothers had a mean age of 44.9 (SD = 
4.6), the majority (52.1%) had completed higher education, 83.3% were married or living 
with their partner and 72.3% had a full- or part-time job. SUD mothers had a mean age of 
49.6 (SD = 4.9), the majority (66%) had completed higher education, 78.7% were married or 
living with their partner and 78.7% had a full- or part-time job. All of the mothers were living 
with their son/daughter. Finally, 25% of the ED mothers and 21.3% of the SUD mothers 
reported having a psychiatric history (χ2 (1) = 0.19, p = .667).  
3.2 Psychiatric comorbidity   
Table 2 shows the DSM-IV Axis I comorbidities in the ED and SUD groups. A total 
of 66% of the ED patients and 68.8% of the SUD patients received a diagnosis of a comorbid 
disorder. The most common diagnosis among the ED group was major depressive disorder 
(66%), which was significantly higher than in the SUD group (χ2 = 7.20, p = .007). Anxiety 
disorders were present in 32% of ED patients and in 4.2% of SUD, with no statistically 
significant differences between groups. Similarly, both groups reported the same rates of 
simple phobia, but the type of phobia differed, with 1 case of nychtophobia in the ED group 
and 1 case of claustrophobia in the SUD group. Externalizing disorders (ADHD, CD and 
ODD) were the most common comorbidities among the SUD group (73%). ADHD was the 
only one of these disorders seen in the ED group (6%), and its prevalence was significantly 
lower than in the SUD group (χ2 = 11.71; p = .001). All ED patients with a comorbid 
diagnosis were female. In the SUD group, 7 females presented a comorbid diagnosis of either 
depression (n = 4), ADHD (n = 1), CD (n = 1) or ODD (n = 1).  
3.3 Mothers’ distress and patients’ variables  
In both groups, significant correlations were found between mother´s HADS scores 
(anxiety and depression subscales) and nearly all patient psychological variables (Table 3). 
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The exception was patient´s anxiety scores, which were not significantly associated with 
mothers’ HADS scores. Mothers of children with a comorbid disorder and those with only a 
primary diagnosis of ED or SUD did not differ in their HADS anxiety (t (91) = -.41, p = .686) 
or depression scores (t (91) = -.85, p = .396).  
3.4 Prediction of patient group based on mothers’ HADS scores and Axis I 
comorbidities  
Table 4 presents results of the two logistic regressions with ED as a reference 
category. The first model was carried out to ascertain the effects of mothers’ depression and 
the presence of one of the three most prevalent Axis I comorbidities (mood disorders, anxiety 
disorders, and ADHD) on the likelihood that patients belonged to the ED or SUD group. The 
logistic regression model was statistically significant, χ2 (4) = 25.36, p < .001. It explained 
34% (Nagelkerke R2) of the variance in the ED group and correctly classified 71.3% of cases. 
Anxiety disorders were 6.1 times more likely and mood disorders were 2.9 times more likely 
to co-occur with an ED. However, ADHD was associated with a reduction in the likelihood 
of belonging to the ED group (5 times less likely). When SUD was used as a reference 
category, as expected, ADHD was 6.4 times more likely to co-occur with SUD, and mood 
and anxiety disorders were associated with a reduction in the likelihood of belonging to the 
SUD group (2.9 and 6.2 times, respectively).  Similarly, when mothers’ anxiety was entered 
in a new logistic regression model to replace mothers’ depression, the model proved to be 
statistically significant, (χ2 (4) = 25.18, p < .001. It explained 32% (Nagelkerke R2) of the 
variance and correctly classified 67.7% of the cases. Mother’s anxiety and depression were 
not significant predictors in the models.  
4. Discussion 
This study revealed that comorbid psychiatric disorders were present in over half of 
the patients (66% for the ED group and 68.8% for the SUD group). Despite the fact that EDs 
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and SUDs share a complex interaction of genetic, biological and personality vulnerabilities, 
environmental and familial factors (Baker Dennis & Brewerton, 2014), findings suggest that 
the type of psychiatric comorbidities may be specific to each illness. The most frequent 
clinical manifestations for the ED group were internalizing disorders (i.e. mood and anxiety 
disorders) whereas for the SUD group externalizing disorders (i.e. ADHD, CD and ODD) 
were most common, which was further supported by results of the logistic regression. These 
findings are similar to those found in prior studies employing standardized diagnostic 
interviews to assess rates of Axis I disorders among treatment seeking adolescent patients 
with ED (Bühren et al., 2014; Salbach-Andrae et al., 2008) and SUD (Chan et al., 2008), as 
well as Spanish adolescent community samples in Spain with ED (Rojo et al., 2003). The one 
exception was the complete absence of OCD among the ED group, which is contrary to 
findings from prior studies (Swinbourne & Touyz, 2007). One possible explanation is that 
patients with OCD could have been seen in other units of the psychiatric department. 
According to Toro and Vilardell (1987), in AN patients with comorbid OCD, symptoms of 
AN can remit following successful treatment for OCD.  
A discussion of these findings also requires consideration of the differences in gender 
composition between the two groups. The primarily male SUD group and primarily female 
ED group raise the question of whether these comorbidities are not specific to the patient 
group, but rather a result of gender. Externalizing disorders tend to be more frequent in male 
adolescents males, while internalizing disorders are more frequent in females (Scaramella, 
Conger, & Simons, 1999). While we cannot definitively conclude whether it is the primary 
diagnosis or the gender that is associated with the particular comorbid diagnoses, these 
results do confirm that the gender composition and Axis I comorbidities of each patient group 
were similar to those found in previous studies employing adolescent treatment seeking ED 
and SUD samples from other countries (Couwenbergh et al., 2006; Herpertz-Dahlmann et al., 
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2001; Schmidt et al., 2008).  Therefore, these findings may be generalizable to treatment 
settings both inside and outside of Spain. Results point to the importance of assessing for 
comorbid symptoms in treatment seeking ED and SUD patients, and are suggestive of the 
most common comorbid diagnoses which clinicians may encounter, which may help to guide 
and improve treatment interventions (Askey, 2007; Milos, Spindler, Buddeberg, & Crameri, 
2003).   
Furthermore, these findings provide a foundation upon which to address future 
research questions regarding treatment seeking adolescent patients with ED or SUD. Previous 
research demonstrates that many individuals with these disorders have never received 
treatment (Bijl & Ravelli, 2000; Compton, Thomas, Stinson, & Grant, 2007), and future 
studies could explore the possibility of unmet care needs among Spanish adolescents with ED 
or SUD. A recent survey carried out in Spain showed that 14.4 to 47.6% of adolescents, 
depending on their age, presented risky alcohol consumption, with greater rates among 
females than males (Health Social Services and Equality Ministry, 2016). However, only a 
small percentage of our SUD sample (12.5%) presented a diagnosis of alcohol abuse and only 
16.7% were female. Future studies could investigate the role of gender, cultural norms 
regarding drugs and alcohol, and the presence of externalizing disorders (and their associated 
interpersonal, familial and legal consequences) in seeking treatment for SUD in Spain. The 
role of gender in seeking or receiving ED treatment for adolescent males could also be 
explored. While research on body dissatisfaction and EDs in males has advanced in recent 
years (Raevuori, Keski-Rahkonen, & Hoek, 2014), they continue to be seen as a “women’s 
illness.” This may lead males to delay seeking treatment (Räisänen & Hunt, 2014), to present 
EDs in ways that require less intensive treatment, or professionals themselves may fail to 
recognize ED symptoms in males (Greenberg & Schoen, 2008).  
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 It is common for both EDs and substance abuse to begin during adolescence, a 
developmental stage in which individuals are particularly vulnerable to developing addictive 
behaviors (Barbarich-Marsteller, Foltin, & Walsh, 2011). Adolescents are exposed to a 
number of pressures, such as acceptance by their peers, experimentation with “adult” 
behaviors, and overwhelming feelings of distress and painful self-awareness. While all 
adolescents may experience these pressures to a greater or lesser degree, seen from the 
perspective of the developmental psychopathology principle of multifinality (Cicchetti & 
Rogosch, 1996), not all of them will present the same outcome (e.g. type of 
psychopathology). While these groups of patients differed in terms of the manifestation of 
their symptoms (both the primary and comorbid diagnoses), they may be representations of 
underlying levels of distress intolerance (Daughters et al., 2009).  
In terms of the second aim of the study, our hypotheses were partially supported. 
Anxiety and depression in both groups of mothers were associated with patients’ levels of 
depression and symptom severity, but not with patients´anxiety. This is similar to recent 
cross-sectional studies exploring the relationship between parental and adolescent 
psychopathology in which maternal mental health has been shown to be associated with both 
internalizing and externalizing disorders (Ranøyen, Klöckner, Wallander, & Jozefiak, 2015; 
Van Loon, Van de Ven, Van Doesum, Witteman, & Hosman, 2014). According to the 
interpersonal maintenance model of AN (Treasure & Schmidt, 2013), these correlations may 
be indicative of the vicious cycle of maintenance in which parental psychological distress 
may increase in the face of ED symptoms, thereby leading to unhelpful responses to the 
illness, which then serve to worsen the prognosis (Treasure & Schmidt, 2013). While initial 
empirical support suggests that parental distress leads to worse distress and symptoms in ED 
patients (Goddard et al., 2013), future longitudinal studies would allow us to elucidate if 
maternal distress serves as a risk or maintenance factor for ED, as well as SUD and the 
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common comorbid mental illnesses identified in this study (Anastasiadou et al., 2016). A 
recent meta-analysis found that interventions targeted specifically at those caring for 
someone with an ED are effective at reducing caregiver distress (Hibbs, Rhind, Leppanen, & 
Treasure, 2015). Future studies could explore the effectiveness of similar interventions in 
SUD parents and caregivers.  
In addition to those already noted, certain study limitations must be considered. First, 
the cross-sectional design does not permit us to draw causal relationships between the 
primary psychiatric disorders and their comorbidities. Longitudinal studies would allow us to 
discover if adolescents with higher rates of internalizing behaviors are more likely to engage 
in ED-related behaviors than to experiment with drugs, and if those with externalizing 
behaviors are more inclined to do the opposite. Furthermore, it would allow researchers to 
observe the development and trajectory of EDs and their associated comorbidities. Future 
studies may also benefit from recruiting larger samples in order to assess for differences in 
comorbidity or maternal mental health between patients in early, middle and late 
adolescence. 
Another limitation involves the differences between the two patient groups in terms of 
gender, age and illness duration. While this was expected given the specific characteristics of 
each condition (Brady & Randall, 1999; Currin, Schmidt, Treasure, & Jick, 2005; R. C. 
Kessler et al., 2005; R. D. Kessler et al., 2007), it remains relevant to note that these 
differences may have had an indirect effect, which could not be examined due to the design 
of the present study. The strict exclusion criteria established for this study added a further 
limitation. The decision to exclude patients with comorbid SUD and ED prohibited us from 
detecting the frequency of the co-occurrence of ED and SUD, which is a finding that has 
been reported in previous studies (Couwenbergh et al., 2006; Salbach-Andrae et al., 2008).  
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The findings of the present study, which employed a semi-structured diagnostic 
interview, reveal a high frequency of psychiatric comorbidities in adolescent patients seeking 
treatment for their ED or SUD in Spain. Furthermore, the most common comorbid mental 
illnesses were distinct in each group. While these groups differed in terms of certain 
demographic and clinical variables, their representativeness increases the generalizability of 
the findings.  Clinicians must take care to not only treat the symptomatology associated with 
the patient´s primary diagnosis, but also assess for the highly likely occurrence of comorbid 
symptomatology, as psychiatric comorbidy is associated with worse prognosis in both patient 
groups (Grella et al., 2001; Herpertz-Dahlmann et al., 2001). In recent years, both SUD and 
ED treatment and research have seen a shift from seeing parents as part of the problem to part 
of the solution (Orford et al., 2010; Treasure, Schmidt, & Macdonald, 2009). The current 
findings suggest that maternal distress may be an appropriate treatment target in interventions 
directed at parents and caregivers.   
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Table 1 
Sociodemographic and clinical data of young participants  
 
 
ED group 
N = 50 
SUD group 
N = 48 
All  
N = 98 
t-test or χ2 test  
 Mean (SD)    
Age (years) 14.78 (1.79) 18.19 (2.17) 16.45 (2.61) t = -8.5,  p < .001 
Illness duration  
(months from detection) 
15.22 (11.79) 33.96 (21.01) 24.40 (19.31) t =-5.47, p < .001 
Treatment duration (weeks) 19.73 (39.91) 27.32 (26.63) 23.45 (34.10) t =-1.09, p = .278 
Body Mass Index (kg/m2) 18.14 (1.82) 21.34 (2.12) 19.39 (2.50) t = -7.29,  p < .001 
 N (%)    
Sex 
Female 
Male 
 
49 (98.0%) 
1 (2.0%) 
 
8 (16.7%) 
40 (83.3%) 
 
57 (58.2%) 
41 (41.8%) 
 
χ2 = 66. 58 , p < .001 
Diagnosis 
Anorexia Nervosa Restrictive type 
Bulimia Nervosa Non Purging type 
Eating Disorder Not Otherwise 
Specified (Restrictive type) 
Alcohol Abuse 
Substance (Cannabis) Abuse 
Substance (Cannabis) Dependence 
 
39 (78.0%) 
3 (6.0%) 
 
8 (16.0%) 
0 
0 
0 
 
0 
0 
 
0 
6 (12.5%) 
47 (97.9%) 
30 (62.5%) 
 
39 (39.8%) 
3 (3.1%) 
 
8 (8.2%) 
6 (6.1%) 
47 (48%) 
30 (30.1%) 
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Table 2 
Comorbid DSM-IV Axis I diagnoses (K-SADS) for each patient group  
 ED group 
N = 50 
SUD group 
N = 48 
All patients 
N = 98 
χ2-test or Fisher 
Exact test 
Any Axis I diagnosis 
 
33 (66.0%) 33 (68.8%) 66 (67.3) χ2 = 0.84, p = .772 
Major depressive disorder 
 
28 (56.0%) 14 (29.2%) 
 
42 (42.9%) χ2 = 7.20, p = .007 
Dysthymic disorder 
 
1 (2.0%) 0 
 
1 (1.0%)  
Panic disorder without agoraphobia 7 (14.0%) 
 
0 7 (7.1%)  
Panic disorder with agoraphobia 
 
1 (2.0%) 0 
 
1 (1.0%)  
Simple phobia 
 
1 (2.0%) 1 (2.1%) 2 (2.0%)  
Social phobia 2 (4.0%) 0 
 
2 (2.0%)  
Generalized anxiety disorder 2 (4.0%) 1 (2.1%) 3 (3.1%) 
 
p = .999 
Separation anxiety disorder 
 
3 (6.0%) 0 3 (3.1%)  
Obsessive-compulsive disorder 
 
0 0 0   
Attention-deficit/hyperactivity disorder 3 (6.0%) 16 (33.3%) 
 
19 (19.4%) χ2 = 11.71, p = .001 
Conduct disorder 
 
0 9 (18.8%) 9 (9.2%)  
Oppositional defiant disorder 
 
0 10 (20.8%) 
 
10 (10.2%)  
Self-harm/Suicidal ideation 
 
Self-harm/Suicidal intention 
 
Self-harm/Suicide attempts 
20 (40.0%) 
 
7 (14.0%) 
 
8 (16.0%) 
 
14 (29.8%) 
 
4 (8.3%) 
 
8 (16.7%) 
34 (34.7%) 
 
11 (11.2%) 
 
16 (16.3%) 
χ2 = 1.27, p = .260 
 
χ2 = 0.79, p = .374 
 
χ2 = 0.01, p = .929 
Running Head: COMORBIDITY IN ADOLESCENT EATING DISORDER PATIENTS 
 
Table 3 
Pearson correlations between mothers’ HADS scores and patients’ scores on psychological measures 
Measures 1 2 3 4 
EDs (N=48) 
(1) HADS-Depression/child 
    
(2) HADS-Anxiety/child .75***    
(3) EAT-26/child .62*** .66***   
(4) HADS-Depression/mothers .30* .20 .38**  
(5) HADS-Anxiety/mothers 
 
SUDs (N=38) 
(1) HADS-Depression/child 
(2) HADS-Anxiety/child 
(3) DAST-20/child 
(4) HADS-Depression/mothers 
(5) HADS-Anxiety/mothers 
.29* 
 
 
 
.67*** 
.48** 
.52*** 
.46** 
.27 
 
 
 
 
.55*** 
.26 
.19 
.49*** 
 
 
 
 
 
.34* 
.31* 
.73*** 
 
 
 
 
 
 
.75*** 
Note. HADS-Depression/child=Hospital Anxiety and Depression Scale-Depression subscale for group of adolescents listed in heading (ED or SUD); HADS-Anxiety/child= Hospital Anxiety and 
Depression Scale-Anxiety subscale/child; EAT-26/child=Eating Attitudes Test for group of adolescents listed; HADS-Depression/mothers=Hospital Anxiety and Depression Scale-Depression 
subscale/group of mothers; HADS-Anxiety/mothers=Hospital Anxiety and Depression Scale-Anxiety subscale/group of mothers;  DAST-20/child=Drug Abuse Screening Test for SUD patients.  
 
* p<.05;  ** p<.01; ***p<.001 
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Table 4 
Logistic regressions predicting child’s primary diagnosis (ED used as reference category) 
Predictors OR 95% CI Overall test of effect 
   B S.E. Wald χ2 df p-value 
Model 1        
Mothers’ HADS-Depression 2.3 0.5-10.8 0.84 0.78 1.2 1 .282 
Axis I comorbidities        
Mood disorders 2.9 1.1-8.0 1.07 0.51 4.3 1 .037 
Anxiety disorders 6.1 1.1-33.4 1.80 0.87 4.3 1 .039 
Attention-deficit/hyperactivity disorder 0.2 0.04-0.7 -1.85 0.73 6.5 1 .011 
Model 2        
Mothers’ HADS-Anxiety 1.8 0.7-4.8 0.59 0.49 1.4 1 .230 
Axis I comorbidities        
Mood disorders 2.5 1.0-6.5 0.93 0.48 3.7 1 .054 
Anxiety disorders 7.9 1.4-43.7 2.07 0.87 5.6 1 .018 
Attention-deficit/hyperactivity disorder 0.2 0.04-0.7 -1.74 0.70 6.1 1 .013 
Note. CI = Confidence interval for odds ratio (OR) 
